A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation

References

• Abdelbary A, Elshafeey AH, Zidan G. (2009). Comparative effects of different cellulosic-based directly compressed orodispersable tablets on oral bioavailability of famotidine. Carbohyd Polym 77:799–806
   Web of Science ®Google Scholar
• Al-Khattawi A, Mohammed AR. (2013). Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert Opin Drug Deliv 10:651–63
   PubMed Web of Science ®Google Scholar
• Alli SMA. (2011). Orally disintegrating drug delivery systems: a technical note on technologies and issues. Int J Pharm Front Res 1:38–55
   Google Scholar
• Bolhuis GK, Zuurman K, Wierik Te GHP. (1997). Improvement of dissolution of poorly soluble drugs by solid deposition on a super disintegrant. II. The choice of super disintegrants and effect of granulation. Eur J Pharm Sci 5:63–9
   Web of Science ®Google Scholar
• British Pharmacopoeia  (2007). The stationary Office under license from the controller of Her Majestys Stationary office for the department of health: A11, A112, A153
   Google Scholar
• British Pharmacopoeia. (2013) . Published by The Stationery Office on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA), London
   Google Scholar
• Caramella C, Ferrari F, Bonferoni MC, Ronchi M. (1990). Disintegrants in solid dosage forms. Drug Dev Ind Pharm 16:2561–77
   Web of Science ®Google Scholar
• Chang RK, Xiaodi G, Burnside BA, Couch RA. (2000). Fast-dissolving tablets. Pharm Tech 24:52–8
   Google Scholar
• Chou R, Peterson K.Helfand M. (2004). Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 28:140–75
   Google Scholar
• Colombo P, Ubaldo C, Caramella C, et al. (1984). Disintegrating force as a new formulation parameter. J Pharm Sci 73:701–5
   PubMed Web of Science ®Google Scholar
• Dixit RP, Puthli SP. (2009). Oral strip technology: overview and future potential. J Control Release 139:94–107
   PubMed Web of Science ®Google Scholar
• European Pharmacopeia. (2009). Sixth edition, published by Council of Europe, Stasbourge, France: 1169–70
   Google Scholar
• European Pharmacopoeia  (2002). Published by the directorate for the quality of medicines of the council of Europe 9EDQM, Strasbourg, France
   Google Scholar
• Florey K, Al-Badr AA, Brenner Gerald S. (1987). Analytical profiles of drug substances. London: Academic Press Inc., 137
   Google Scholar
• Gohel M, Patel M, Amin A, et al (2004). Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS Pharm Sci Tech 5:10–15
   Web of Science ®Google Scholar
• Heer DA, Geeta A, Kumar SH. (2013). Recent trends of fast dissolving drug delivery system–an overview of formulation technology. Pharmacophore 4:1–9
   Google Scholar
• Honey G, Parshuram R, Rana V, Tiwary AK. (2008). Orally disintegrating systems: innovations in formulation and technology. Recent Pat Drug Deliv Formul 2:258–74
   PubMedGoogle Scholar
• Jacob S, Shirwaikar AA, Joseph A, Srinivasan KK. (2007). Novel co-processed excipients of mannitol and microcrystalline cellulose for preparing fast dissolving tablets of glipizide. Ind J Pharm Sci 69:633
   Google Scholar
• Kuno Y, Kojima M, Ando S, Hiroaki N. (2005). Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. J Control Release 105:16–22
   PubMed Web of Science ®Google Scholar
• Mizumoto T, Masuda Y, Yamamoto T, et al (2005). Formulation design of a novel fast-disintegrating tablet. Int J Pharm 306:83–90
   PubMed Web of Science ®Google Scholar
• Mrhar A, Baumgartner S. (2008). 7th Central European Symposium on Pharmaceutical Technology and Biodelivery Systems, September 18-20, 2008, Hotel Mons, Ljubljana, Slovenia: Proceedings from the Symposium, Slovenian Pharmaceutical Society
   Google Scholar
• Nagaraju T, Gowthami R, Rajashekar M, Sandeep S, Mallesham M, Sathish D, Shravan Kumar Y. (2013). Comprehensive review on oral disintegrating films. Curr Drug Deliv 10:96108
   Google Scholar
• Ochu SN. (2009). Evaluation of barley (Hordeum vulgare) starch as a tablet excipient. MSc Thesis submitted to Ahmadu Bello, University of Zaria, Nigeria
   Google Scholar
• Patel M, Patel N, Patel M. (2007). Fast-dissolving rofecoxib tablets: formulation development & optimization using factorial design. Drug Del Technol 7:33–8
   Google Scholar
• Sammour OA, Hammad Mohammed A, Megrab Nagia A, Zidan Ahmed S. (2006). Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech 7:E167–75
   Web of Science ®Google Scholar
• Seager H. (1998). Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol 50:375–82
   PubMed Web of Science ®Google Scholar
• Selkirk AB, Ganderton D. (1970). An investigation of the pore structure of tablets of sucrose and lactose by mercury porosimetry. J Pharm Pharmacol 22:79S–85S
   Web of Science ®Google Scholar
• Shafei AH. (1998). Master Thesis, Cairo University, Cairo, Egypt, 51
   Google Scholar
• Shoukri RA, Iman SA, Shamma RN. (2009). In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm 73:162–71
   PubMed Web of Science ®Google Scholar
• Shu T, Hideshi S, Kenji H, Ito K. (2002). Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull 50:193–8
   PubMed Web of Science ®Google Scholar
• Stoltenberg I, Breitkreutz J. (2011). Orally disintegrating mini-tablets (ODMTs)-a novel solid oral dosage form for paediatric use. Eur J Pharm Biopharm 78:462–9
   PubMed Web of Science ®Google Scholar
• Sunada H, Bi Y. (2002). Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 122:188–98
   Web of Science ®Google Scholar
• Suresh S, Pandit P, Joshi HP. (2007). Preparation and evaluation of mouth dissolving tablets of salbutamol sulphate. Ind J Pharm Sci 69:467
   Google Scholar
• Sweetman SC, Pharm B, PharmS FR. (2009). Martindale: the complete drug reference. 36th ed. London, UK: The Pharmaceutical Press, an imprint of RPS Publishing
   Google Scholar
• Tayel SA. (2013). Pharmaceutical study on an antimigraine drug. Ph.D thesis submitted from Mohammed Hassan, Cairo University, Cairo, Egypt, 107–20
   Google Scholar
• Velmurugan S, Vinushitha S. (2010). Oral disintegrating tablets: an overview. Int J Chem Pharm Sci 1:1–12
   Google Scholar
• Wilson CG, Washington N, Peach J, et al (1987). The behaviour of a fast-dissolving dosage form (Expidet) followed by γ-scintigraphy. Int J Pharm 40:119–23
   Web of Science ®Google Scholar
• Xu WJ, Xie H-J, Cao QR, et al (2014). Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers. Drug Deliv 23:41–8
   Web of Science ®Google Scholar
• Zhang S-J, Xu Wei R. (2003). Study on bioequivalence of chlorzoxazone tablets in Chinese volunteers. Asi J Drug Metab Ph 4:53–6
   Google Scholar
• Zhao N, Augsburger LL. (2005). Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution. AAPS PharmSciTech 6:E634–40
   PubMed Web of Science ®Google Scholar